Ledger.Open graph →
SEC Form D · filed August 10, 2023

ADARx Pharmaceuticals, Inc

Offering
$200.0M
Sold
$200.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Zhen Li · San Diego, CAExec · Director · PromoterRui Zhu · San Diego, CAExecCarl Gordon · SAN FRANCISCO, CADirectorWilliam P. Connor · Houston, TXExec · Director · PromoterSimeon George · Cambridge, MADirectorJudith Li · Danvers, MADirectorErez Chimovits · Tel Aviv, L3DirectorSheila Gujrathi · San Diego, CADirectorYuan (Eliza) Sun · San Diego, CADirectorChen Yu · Palo Alto, CADirectorRicky Sun · San Diego, CADirectorLorence Kim · Cambridge, MADirectorCarl Gordon · Encinitas, CADirectorRuss Ivinjack · Chicago, ILExec · Director · PromoterRui Zhu · San Diego, CAExecSimeon George · Menlo Park, CADirectorJudith Li · Danvers, MADirectorErez Chimovits · Herzeliya, L3DirectorSheila Gujrathi · La Jolla, CADirectorYuan (Eliza) Sun · San Diego, CADirectorChen Yu · Palo Alto, CADirectorRicky Sun · San Diego, CADirectorLorence Kim · Cambridge, MADirectorCarl Gordon · CAMBRIDGE, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗